Glaxosmithkline PLC, Director at Decibel Therapeutics, Inc. (DBTX), bought 477,852 shares at $18.00 ($2.7M) on 2021-02-17, disclosed to the SEC on 2021-02-19.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 327,852 | $0 | 0.0% |
| 2 | $18.00 | 150,000 | $2.7M | 100.0% |
| Total | $5.65 avg | 477,852 | $2.7M | 100% |
| Filing → |
| BCYC | SELL | 2020-09-18 | $151K | — | Filing → |
| GNCA | BUY | 2020-07-30 | $2.8M | — | Filing → |
| PAND | BUY | 2020-07-22 | $6.5M | — | Filing → |